US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Patient Dosing

Recent news which mentions Patient Dosing

Lyra's Mid-Stage Chronic Rhinosinusitis Candidate Study Progressed, Shares Fall
Tickers LYRA
Tags Market News Patient Dosing Health Care
From Benzinga
Emergent Shares Decline Following Commencement Of Initial-Stage Lassa Virus Vaccine Candidate Study
Tickers EBS
Tags Small Cap EBS Patient Dosing
From Benzinga
Werewolf Shares Climb As Initial-Stage Solid Tumors Study Kicks-off
Tickers HOWL
Tags General Benzinga Biotech
From Benzinga
Geron Commences Initial-Stage Rare Blood Cancer Combination Study
Tickers GERN
Tags Penny Stocks General GERN
From Benzinga
Kronos Bio Shares Fall After Initial-Stage Blood Cancer Study Takes-off
Tickers KRON
Tags Benzinga Biotech General
From Benzinga
Graphite Bio Shares Soar As Initial-Stage Blood Cell Disorder Study Launched
Tickers GRPH
Tags Biotech GRPH Benzinga
From Benzinga
Passage Bio Commences Initial-Stage Brain Disorder Study
Tickers PASG
Tags Benzinga Biotech Penny Stocks
From Benzinga
Capricor Initiates Late-Stage Neuropsychiatric Disorder Study
Tickers CAPR
Tags Health Care Patient Dosing Market News
From Benzinga
Impel Commences Mid-Stage Autism Spectrum Disorder Study
Tickers IMPL
Tags Biotech Benzinga General
From Benzinga
Pulmatrix Commences Initial-Stage Acute Migraine Study
Tickers PULM
Tags General Penny Stocks PULM
From Benzinga
Synlogic Initiates Initial-Stage Homocystinuria Study
Tickers SYBX
Tags Market News SYBX Patient Dosing
From Benzinga
Immunocore Commences Initial-Stage HIV Study
Tickers IMCR
Tags Hedge Funds Market News Patient Dosing
From Benzinga
Calithera Commences Mid-Stage Study Of DLBCL Candidate
Tickers CALA
Tags Health Care Patient Dosing Market News
From Benzinga
Biomea Fusion Commences Initial-Stage Study For Plasma Cell Cancer Setting
Tickers BMEA
Tags Patient Dosing Market News Health Care
From Benzinga